{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:20:59Z","timestamp":1775082059968,"version":"3.50.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-025-03225-1","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T18:43:23Z","timestamp":1763491403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Current Strategies in the Development of Nanoformulations to Enhance the Stability of Botox: A Systematic Review"],"prefix":"10.1208","volume":"27","author":[{"given":"Nazanin","family":"Ajdary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Shafiee Ardestani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hasti","family":"Nequi Marnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Eshrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7277-1103","authenticated-orcid":false,"given":"Tahereh","family":"Zadeh Mehrizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"issue":"2","key":"3225_CR1","doi-asserted-by":"publisher","first-page":"777","DOI":"10.3390\/ijms26020777","volume":"26","author":"R Kumar","year":"2025","unstructured":"Kumar R, Singh BR. Botulinum toxin: a comprehensive review of its molecular architecture and mechanistic action. Int J Mol Sci. 2025;26(2):777.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3225_CR2","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/toxins16020096","volume":"16","author":"L Rempel","year":"2024","unstructured":"Rempel L, Malik RN, Shackleton C, Calder\u00f3n-Ju\u00e1rez M, Sachdeva R, Krassioukov AV. From toxin to treatment: a narrative review on the use of botulinum toxin for autonomic dysfunction. Toxins. 2024;16(2):96.","journal-title":"Toxins"},{"key":"3225_CR3","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/164_2020_355","volume":"263","author":"O Rossetto","year":"2021","unstructured":"Rossetto O, Pirazzini M, Fabris F, Montecucco C. Botulinum neurotoxins: mechanism of action. Botulinum Toxin Therapy. 2021;263:35\u201347.","journal-title":"Botulinum Toxin Therapy."},{"issue":"7","key":"3225_CR4","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/toxins16070309","volume":"16","author":"D Onan","year":"2024","unstructured":"Onan D, Farham F, Martelletti P. Clinical conditions targeted by onabotulinumtoxinA in different ways in medicine. Toxins. 2024;16(7):309.","journal-title":"Toxins"},{"key":"3225_CR5","doi-asserted-by":"crossref","unstructured":"Wong ZY, Damavandi P, Richards M, Danpanichkul P, Adegboye O, Faderani R, et al., editors. Botulinum toxin in aesthetic medicine: a bibliometric analysis of research trends and methodological quality of the top 100 cited publications. Aesthet Surg J Open Forum. 2025;7:ojae131.","DOI":"10.1093\/asjof\/ojae131"},{"issue":"2","key":"3225_CR6","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/2211738511666230825150259","volume":"12","author":"SD Kadir","year":"2024","unstructured":"Kadir SD. Industrial production and therapeutic application of botulinum neurotoxin: the role of C. botulinum type A. Pharm Nanotechnol. 2024;12(2):99\u2013107.","journal-title":"Pharm Nanotechnol"},{"key":"3225_CR7","doi-asserted-by":"publisher","first-page":"N-A","DOI":"10.20517\/2347-9264.2023.90","volume":"11","author":"S Gupta","year":"2024","unstructured":"Gupta S, Sudharshan R, Shen A, Zhang-Nunes S, Siperstein R. Updated review on neuromodulators. Plast Aesthet Res. 2024;11:N-A.","journal-title":"Plast Aesthet Res"},{"issue":"6","key":"3225_CR8","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3390\/toxins16060261","volume":"16","author":"C Rasetti-Escargueil","year":"2024","unstructured":"Rasetti-Escargueil C, Palea S. Embracing the versatility of botulinum neurotoxins in conventional and new therapeutic applications. Toxins. 2024;16(6):261.","journal-title":"Toxins"},{"issue":"3","key":"3225_CR9","doi-asserted-by":"publisher","first-page":"e0300157","DOI":"10.1371\/journal.pone.0300157","volume":"19","author":"RS Saini","year":"2024","unstructured":"Saini RS, Ali Abdullah Almoyad M, Binduhayyim RIH, Quadri SA, Gurumurthy V, Bavabeedu SS, et al. The effectiveness of botulinum toxin for temporomandibular disorders: a systematic review and meta-analysis. PLoS ONE. 2024;19(3):e0300157.","journal-title":"PLoS ONE"},{"issue":"4","key":"3225_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.3390\/toxins16040184","volume":"16","author":"S Facciorusso","year":"2024","unstructured":"Facciorusso S, Spina S, Picelli A, Baricich A, Francisco GE, Molteni F, et al. The role of botulinum toxin type-A in spasticity: research trends from a bibliometric analysis. Toxins. 2024;16(4):184.","journal-title":"Toxins"},{"issue":"4","key":"3225_CR11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/toxins16040191","volume":"16","author":"I Demchenko","year":"2024","unstructured":"Demchenko I, Swiderski A, Liu H, Jung H, Lou W, Bhat V. Botulinum toxin injections for psychiatric disorders: a systematic review of the clinical trial landscape. Toxins. 2024;16(4):191.","journal-title":"Toxins"},{"key":"3225_CR12","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/164_2019_342","volume":"263","author":"M Dong","year":"2021","unstructured":"Dong M, Stenmark P. The structure and classification of botulinum toxins. Botulinum Toxin Therapy. 2021;263:11\u201333.","journal-title":"Botulinum Toxin Therapy."},{"issue":"6","key":"3225_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/toxins16060266","volume":"16","author":"MF Brin","year":"2024","unstructured":"Brin MF, Nelson M, Ashourian N, Brideau-Andersen A, Maltman J. Update on non-interchangeability of botulinum neurotoxin products. Toxins. 2024;16(6):266.","journal-title":"Toxins"},{"issue":"1","key":"3225_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3390\/toxins13010058","volume":"13","author":"S Choudhury","year":"2021","unstructured":"Choudhury S, Baker MR, Chatterjee S, Kumar H. Botulinum toxin: an update on pharmacology and newer products in development. Toxins. 2021;13(1):58.","journal-title":"Toxins"},{"key":"3225_CR15","volume-title":"A taste of bioinformatics: Exploring the pathogenetics of clostridium botulinum","author":"E Trudova","year":"2024","unstructured":"Trudova E. A taste of bioinformatics: Exploring the pathogenetics of clostridium botulinum. Master Thesis, Swedish University of Agricultural Sciences; 2024."},{"issue":"9","key":"3225_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/toxins15090550","volume":"15","author":"F Antonucci","year":"2023","unstructured":"Antonucci F, Bozzi Y. Action of Botulinum neurotoxin E type in experimental epilepsies. Toxins. 2023;15(9):550.","journal-title":"Toxins"},{"key":"3225_CR17","unstructured":"Edelson J, Nicolosi R. Botulinum nanoemulsions. U.S. Patent 20140099342 A1. 2014."},{"key":"3225_CR18","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/978-1-4614-9454-6_4","volume-title":"Molecular aspects of botulinum neurotoxin","author":"BR Singh","year":"2014","unstructured":"Singh BR, Chang T-W, Kukreja R, Cai S. The botulinum neurotoxin complex and the role of ancillary proteins. In: Foster KA, editor. Molecular aspects of botulinum neurotoxin. New York: Springer; 2014. p. 69\u2013101."},{"key":"3225_CR19","unstructured":"Lee CG, Oum JH, Ajay V, Gui X. Cell-based method for determining an activity of botulinum toxin. U.S. Patent 20210063383A1. 2021."},{"issue":"10","key":"3225_CR20","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3390\/genes13101915","volume":"13","author":"R Tian","year":"2022","unstructured":"Tian R, Widel M, Imanian B. The light chain domain and especially the C-terminus of receptor-binding domain of the botulinum neurotoxin (BoNT) are the hotspots for amino acid variability and toxin type diversity. Genes. 2022;13(10):1915.","journal-title":"Genes"},{"issue":"1","key":"3225_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/s42004-024-01262-8","volume":"7","author":"M Mart\u00ednez-Carranza","year":"2024","unstructured":"Mart\u00ednez-Carranza M, \u0160kerlov\u00e1 J, Lee P-G, Zhang J, Kr\u010d A, Sirohiwal A, et al. Activity of botulinum neurotoxin X and its structure when shielded by a non-toxic non-hemagglutinin protein. Communications Chemistry. 2024;7(1):179.","journal-title":"Communications Chemistry"},{"key":"3225_CR22","first-page":"15","volume-title":"Molecular Structure, Mode of Action, Immunology, Safety, and Side Effects of BoNTs","author":"B Jabbari","year":"2022","unstructured":"Jabbari B. Molecular Structure, Mode of Action, Immunology, Safety, and Side Effects of BoNTs. Botulinum Toxin Treatment of Pain Disorders: Springer; 2022. p. 15\u201326."},{"issue":"1","key":"3225_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1146\/annurev.biochem.051908.125345","volume":"79","author":"M Montal","year":"2010","unstructured":"Montal M. Botulinum neurotoxin: a marvel of protein design. Annu Rev Biochem. 2010;79(1):591\u2013617.","journal-title":"Annu Rev Biochem"},{"issue":"7","key":"3225_CR24","doi-asserted-by":"publisher","first-page":"BSR20240117","DOI":"10.1042\/BSR20240117","volume":"44","author":"MV Buzzatto","year":"2024","unstructured":"Buzzatto MV, Benegas Guerrero FC, \u00c1lvarez PA, Zizzias MP, Polo LM, Tomes CN. Expression, purification and application of a recombinant, membrane permeating version of the light chain of botulinum toxin B. Biosci Reports. 2024;44(7):BSR20240117.","journal-title":"Biosci Reports"},{"issue":"10","key":"3225_CR25","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/2338","volume":"5","author":"DB Lacy","year":"1998","unstructured":"Lacy DB, Tepp W, Cohen AC, DasGupta BR, Stevens RC. Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nat Struct Biol. 1998;5(10):898\u2013902.","journal-title":"Nat Struct Biol"},{"key":"3225_CR26","unstructured":"Ton JL, Patel HA, Bates RC, Ahmad WM. Process and system for obtaining botulinum neurotoxin. U.S. Patent 8932827B2. 2015."},{"issue":"2","key":"3225_CR27","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/toxins16020101","volume":"16","author":"MU Martin","year":"2024","unstructured":"Martin MU, Frevert J, Tay CM. Complexing protein-free botulinum neurotoxin A formulations: implications of excipients for immunogenicity. Toxins. 2024;16(2):101.","journal-title":"Toxins"},{"key":"3225_CR28","unstructured":"Thompson SA, Ruegg CL, Waugh JM. Albumin-free botulinum toxin formulations. WO Patent 2010151840A2; 2010."},{"key":"3225_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-80671-2","volume-title":"Botulinum toxin in clinical practice","author":"MG Berry","year":"2021","unstructured":"Berry MG. Botulinum toxin in clinical practice. Cham: Springer; 2021."},{"key":"3225_CR30","volume-title":"Structural studies of pH effects on botulinum toxins A & E","author":"CJ Lalaurie","year":"2023","unstructured":"Lalaurie CJ. Structural studies of pH effects on botulinum toxins A & E. PhD Thesis, University College London; 2023."},{"key":"3225_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40199-023-00462-2","volume":"31","author":"N Shabani Ravari","year":"2023","unstructured":"Shabani Ravari N, Sheikhlou MG, Goodarzi N, Kharazian B, Amini M, Atyabi F, et al. Fabrication, characterization and evaluation of a new designed botulinum toxin-cell penetrating peptide nanoparticulate complex. DARU J Pharm Sci. 2023;31:1\u201312.","journal-title":"DARU J Pharm Sci."},{"issue":"2","key":"3225_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.24198\/ijpst.v6i2.56009","volume":"6","author":"RF Nuwarda","year":"2024","unstructured":"Nuwarda RF, Ramadhania ZM, Novianti MT. The stability of protein therapeutics: a significant challenge in the formulation of biopharmaceuticals. Indonesian J Pharm Sci Technol. 2024;6(2):1\u201314.","journal-title":"Indonesian J Pharm Sci Technol"},{"issue":"1","key":"3225_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7181\/acfs.2021.00003","volume":"22","author":"MY Park","year":"2021","unstructured":"Park MY, Ahn KY. Scientific review of the aesthetic uses of botulinum toxin type A. Arch Craniofac Surg. 2021;22(1):1.","journal-title":"Arch Craniofac Surg"},{"issue":"1","key":"3225_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.det.2024.08.004","volume":"43","author":"R Rashied","year":"2025","unstructured":"Rashied R, Gold MH. Innovation in botulinum toxins. Dermatol Clin. 2025;43(1):55\u201366.","journal-title":"Dermatol Clin"},{"issue":"3","key":"3225_CR35","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/SAP.0000000000002994","volume":"88","author":"JL Crook","year":"2022","unstructured":"Crook JL, Jahromi AH, Konofaos P. Long-term effects of repeated botulinum toxin injection in cosmetic therapeutics. Ann Plast Surg. 2022;88(3):345\u201352.","journal-title":"Ann Plast Surg"},{"key":"3225_CR36","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s40265-021-01631-w","volume":"81","author":"N Solish","year":"2021","unstructured":"Solish N, Carruthers J, Kaufman J, Rubio RG, Gross TM, Gallagher CJ. Overview of daxibotulinumtoxinA for injection: a novel formulation of botulinum toxin type A. Drugs. 2021;81:2091\u2013101.","journal-title":"Drugs"},{"issue":"6","key":"3225_CR37","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1111\/jocd.14160","volume":"20","author":"G Kroumpouzos","year":"2021","unstructured":"Kroumpouzos G, Kassir M, Gupta M, Patil A, Goldust M. Complications of botulinum toxin A: an update review. J Cosmet Dermatol. 2021;20(6):1585\u201390.","journal-title":"J Cosmet Dermatol"},{"key":"3225_CR38","first-page":"1210","volume":"45","author":"N Sethi","year":"2021","unstructured":"Sethi N, Singh S, DeBoulle K, Rahman E. A review of complications due to the use of botulinum toxin A for cosmetic indications. Aesthet Surg J. 2021;45:1210\u201320.","journal-title":"Aesthet Surg J"},{"issue":"1\u20134","key":"3225_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1080\/14764172.2024.2374812","volume":"26","author":"B Ebrahimi","year":"2024","unstructured":"Ebrahimi B, Jamzad S, Naseh Z, Moezzi I, Kargar Jahromi H, Naseh M. The efficacy of various interventions as good strategies to reduce pain in botulinum neurotoxin A for wrinkles. A systematic review of the randomized controlled trials (RCTs). J Cosmet Laser Ther. 2024;26(1\u20134):69\u201376.","journal-title":"J Cosmet Laser Ther"},{"issue":"01","key":"3225_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.5999\/aps.2021.00766","volume":"49","author":"SY Wee","year":"2022","unstructured":"Wee SY, Park ES. Immunogenicity of botulinum toxin. Arch Plast Surg. 2022;49(01):12\u20138.","journal-title":"Arch Plast Surg"},{"issue":"10","key":"3225_CR41","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1007\/s12325-021-01882-9","volume":"38","author":"WW Carr","year":"2021","unstructured":"Carr WW, Jain N, Sublett JW. Immunogenicity of botulinum toxin formulations: potential therapeutic implications. Adv Ther. 2021;38(10):5046\u201364.","journal-title":"Adv Ther"},{"issue":"9S","key":"3225_CR42","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1097\/DSS.0000000000004293","volume":"50","author":"E Rahman","year":"2024","unstructured":"Rahman E, Carruthers JDA. Immunogenicity of botulinum toxin A: insights. Dermatol Surg. 2024;50(9S):S117\u201326.","journal-title":"Dermatol Surg"},{"issue":"3","key":"3225_CR43","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s00289-022-04147-9","volume":"80","author":"T Zadeh Mehrizi","year":"2023","unstructured":"Zadeh Mehrizi T. Assessment of the effect of polymeric nanoparticles on storage and stability of blood products (red blood cells, plasma, and platelet). Polym Bull. 2023;80(3):2263\u201398.","journal-title":"Polym Bull"},{"issue":"14","key":"3225_CR44","doi-asserted-by":"publisher","first-page":"2130013","DOI":"10.1142\/S1793292021300139","volume":"16","author":"TZ Mehrizi","year":"2021","unstructured":"Mehrizi TZ. Impact of metallic, quantum dots and carbon-based nanoparticles on quality and storage of albumin products for clinical use. NANO. 2021;16(14):2130013.","journal-title":"NANO"},{"key":"3225_CR45","doi-asserted-by":"publisher","DOI":"10.2174\/0115672018316266240909075316","author":"TZ Mehrizi","year":"2025","unstructured":"Mehrizi TZ, Rezayat SM, Shahmabadi HE. Latest findings on the effects of gold nanoparticles on the storage quality of blood products (2011\u20132022)-a narrative review. Curr Drug Deliv. 2025. https:\/\/doi.org\/10.2174\/0115672018316266240909075316.","journal-title":"Curr Drug Deliv"},{"issue":"3","key":"3225_CR46","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1080\/17435390.2024.2340467","volume":"18","author":"T Zadeh Mehrizi","year":"2024","unstructured":"Zadeh Mehrizi T, Mosaffa N, Vodjgani M, Ebrahimi Shahmabadi H. Advances in nanotechnology for improving the targeted delivery and activity of amphotericin B (2011\u20132023): a systematic review. Nanotoxicology. 2024;18(3):231\u201358.","journal-title":"Nanotoxicology"},{"issue":"7","key":"3225_CR47","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.3390\/polym15071596","volume":"15","author":"A Yusuf","year":"2023","unstructured":"Yusuf A, Almotairy ARZ, Henidi H, Alshehri OY, Aldughaim MS. Nanoparticles as drug delivery systems: a review of the implication of nanoparticles\u2019 physicochemical properties on responses in biological systems. Polymers. 2023;15(7):1596.","journal-title":"Polymers"},{"key":"3225_CR48","doi-asserted-by":"publisher","first-page":"19139","DOI":"10.1021\/acsami.2c01738","volume":"14","author":"JM An","year":"2022","unstructured":"An JM, Shahriar SMS, Lee DY, Hwang SR, Lee Y-k. Pore size-dependent stereoscopic hydrogels enhance the therapeutic efficiency of botulinum toxin for the treatment of nerve-related diseases. ACS Appl Mater Interfaces. 2022;14:19139\u201353.","journal-title":"ACS Appl Mater Interfaces."},{"key":"3225_CR49","unstructured":"Park K, Yun Y, Skidmore SM, Lee BK, Garner JS. Biodegradable polymer formulations for extended efficacy of botulinum toxin. U.S. Patent 20180055779A1. 2018."},{"issue":"24","key":"3225_CR50","doi-asserted-by":"publisher","first-page":"7784","DOI":"10.1039\/D3BM01301D","volume":"11","author":"A Malek-Khatabi","year":"2023","unstructured":"Malek-Khatabi A, Rad-Malekshahi M, Shafiei M, Sharifi F, Motasadizadeh H, Ebrahiminejad V, et al. Botulinum toxin A dissolving microneedles for hyperhidrosis treatment: design, formulation and in vivo evaluation. Biomaterials Science. 2023;11(24):7784\u2013804.","journal-title":"Biomaterials Science"},{"issue":"5S","key":"3225_CR51","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/01.GOX.0000937652.43692.e5","volume":"11","author":"M Bhoopalam","year":"2023","unstructured":"Bhoopalam M, Qiu C, Harris TGW, Tuffaha S, Mao H-Q, Reddy SK. 14. A Tunable Nanoparticle-based Botulinum Toxin Formulation for Extended Duration of Therapeutic Effect. Plast Reconstruct Surg-Global Open. 2023;11(5S):9\u201310.","journal-title":"Plast Reconstruct Surg-Global Open"},{"key":"3225_CR52","unstructured":"Moeller KW, Willoughby AJM. Botulinum toxin and colloidal silver particles. U.S. Patent 20170196946A1. 2017."},{"issue":"10S","key":"3225_CR53","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1097\/01.GOX.0000799792.25384.56","volume":"9","author":"T Harris","year":"2021","unstructured":"Harris T, Qiu C, Colakoglu S, Tuffaha S, Mao H-Q, Reddy SK. Extended local release of neuromodulators from a novel nanoparticle system for chronic migraine and facial aesthetics. Plastic Reconstruct Surg-Global Open. 2021;9(10S):134\u20135.","journal-title":"Plastic Reconstruct Surg-Global Open"},{"issue":"22","key":"3225_CR54","doi-asserted-by":"publisher","first-page":"4973","DOI":"10.12998\/wjcc.v12.i22.4973","volume":"12","author":"R-J Wang","year":"2024","unstructured":"Wang R-J, Wang Y, Wu J-F, Si T-T. Clinical effect of botulinum toxin type A combined with autologous fat grafting in patients with nasolabial fold depression. World J Clin Cases. 2024;12(22):4973.","journal-title":"World J Clin Cases"},{"issue":"4S","key":"3225_CR55","doi-asserted-by":"publisher","first-page":"e398","DOI":"10.1016\/j.juro.2015.02.674","volume":"193","author":"K Stav","year":"2015","unstructured":"Stav K, Vinshtok Y, Jeshurun M, Ivgy-May N, Gerassi T, Zisman A. PD20-03 pilot study evaluating safety and feasibility of intravesical instillation of botulinum toxin in hydrogel-based slow release delivery system in PBS\/IC patients. J Urol. 2015;193(4S):e398-e.","journal-title":"J Urol"},{"issue":"2","key":"3225_CR56","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5213\/inj.2142124.062","volume":"26","author":"Q Liu","year":"2022","unstructured":"Liu Q, Liao L. Nano-BTA: a new strategy for intravesical delivery of botulinum toxin A. Int Neurourol J. 2022;26(2):92.","journal-title":"Int Neurourol J"},{"issue":"43","key":"3225_CR57","doi-asserted-by":"publisher","first-page":"926","DOI":"10.5897\/AJPP2016.4636","volume":"10","author":"DPSF Assuncao","year":"2016","unstructured":"Assuncao DPSF, Farago PV, Grassiol S, Justus B, Budel JM, Goncalves MM, et al. Development, characterization and assessment of botulinum toxin type A incorporated in nanocarriers. Afr J Pharm Pharmacol. 2016;10(43):926\u201335.","journal-title":"Afr J Pharm Pharmacol"},{"key":"3225_CR58","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.urology.2017.12.028","volume":"114","author":"YH Rappaport","year":"2018","unstructured":"Rappaport YH, Zisman A, Jeshurun-Gutshtat M, Gerassi T, Hakim G, Vinshtok Y, et al. Safety and feasibility of intravesical instillation of botulinum toxin-A in hydrogel-based slow-release delivery system in patients with interstitial cystitis-bladder pain syndrome: a pilot study. Urology. 2018;114:60\u20135.","journal-title":"Urology"},{"issue":"3","key":"3225_CR59","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1111\/1541-4337.13139","volume":"22","author":"H Cheng","year":"2023","unstructured":"Cheng H, Chen W, Jiang J, Khan MA, Wusigale Liang L. A comprehensive review of protein-based carriers with simple structures for the co-encapsulation of bioactive agents. Compr Rev Food Sci Food Saf. 2023;22(3):2017\u201342.","journal-title":"Compr Rev Food Sci Food Saf"},{"issue":"6","key":"3225_CR60","doi-asserted-by":"publisher","first-page":"142","DOI":"10.26689\/jcnr.v6i6.4537","volume":"6","author":"Xi Yang","year":"2022","unstructured":"Yang Xi, HQ. Clinical observation of botulinum toxin type A combined with nanofat in facial rejuvenation treatment. J Clin Nurs Res. 2022;6(6):142\u20136.","journal-title":"J Clin Nurs Res"},{"issue":"6S","key":"3225_CR61","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/01.GOX.0000842512.01197.ca","volume":"10","author":"TGW Harris","year":"2022","unstructured":"Harris TGW, Qiu C, Colakoglu S, Tuffaha S, Mao H-Q, Reddy S. Nanomaterial-based Neuromodulators for Extended Duration of Therapeutic Effect. Plast Reconstruct Surg-Global Open. 2022;10(6S):31.","journal-title":"Plast Reconstruct Surg-Global Open"},{"key":"3225_CR62","unstructured":"Xiang H, Luo M Wang P, Donovan S. Animal product free system and process for purifying a botulinum toxin. U.S. Patent 8409828B2. 2012."},{"key":"3225_CR63","unstructured":"Weder HG, Mutsch M. Process for the production of a nanoemulsion of oil particles in an aqueous phase. U.S. Patent 5152923A. 1992."},{"key":"3225_CR64","unstructured":"Amselem S, Friedman D. Solid fat nanoemulsions as drug delivery vehicles. EP Patent 0702552A1. 1996."},{"key":"3225_CR65","unstructured":"Tabibi SE, Mendes RW, Pathak NP. Controlled release aqueous emulsion. EP Patent 0773780B1. 1997."},{"key":"3225_CR66","unstructured":"Ribier A, Simonnet J-T, Legret S. Transparent nanoemulsion less than 100 nm based on fluid non-ionic amphiphilic lipids and use in cosmetic or in dermopharmaceuticals. U.S. Patent 5753241A. 1998."},{"key":"3225_CR67","unstructured":"Franco P, Heine J. Water-thin emulsion formed by high pressure homogenization process. WO Patent 1998047464A1. 1998."},{"issue":"3","key":"3225_CR68","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S0168-3659(96)01609-4","volume":"46","author":"U Schmalfuss","year":"1997","unstructured":"Schmalfuss U, Neubert R, Wohlrab W. Modification of drug penetration into human skin using microemulsions. J Control Release. 1997;46(3):279\u201385.","journal-title":"J Control Release"},{"issue":"10","key":"3225_CR69","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3390\/toxins15100619","volume":"15","author":"S Sattler","year":"2023","unstructured":"Sattler S, Gollomp S, Curry A. A narrative literature review of the established safety of human serum albumin use as a stabilizer in aesthetic botulinum toxin formulations compared to alternatives. Toxins. 2023;15(10):619.","journal-title":"Toxins"},{"key":"3225_CR70","unstructured":"Allison A. Covalent coupling of botulinum toxin with polyethylene glycol. WO Patent 2003000193A2. 2001."},{"issue":"6","key":"3225_CR71","doi-asserted-by":"publisher","first-page":"e39670","DOI":"10.1371\/journal.pone.0039670","volume":"7","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Kang L, Gao S, Gao X, Xin W, Wang J. Peg precipitation coupled with chromatography is a new and sufficient method for the purification of botulinum neurotoxin type B. PLoS ONE. 2012;7(6):e39670.","journal-title":"PLoS ONE"},{"issue":"1","key":"3225_CR72","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41536-024-00354-2","volume":"9","author":"N Mahheidari","year":"2024","unstructured":"Mahheidari N, Kamalabadi-Farahani M, Nourani MR, Atashi A, Alizadeh M, Aldaghi N, et al. Biological study of skin wound treated with alginate\/carboxymethyl cellulose\/chorion membrane, diopside nanoparticles, and Botox A. NPJ Regen Med. 2024;9(1):9.","journal-title":"NPJ Regen Med"},{"key":"3225_CR73","unstructured":"Donovan S. Biodegradable botulinum toxin implant. U.S. Patent 20020028244A1. 2002."},{"key":"3225_CR74","doi-asserted-by":"publisher","DOI":"10.1089\/adt.2024.122","author":"S Joshi","year":"2025","unstructured":"Joshi S, Jindal P, Gautam S, Singh C, Patel P, Gupta GD, et al. Mini review on the lyophilization: a basic requirement for formulation development and stability modifier. Assay Drug Dev Technol. 2025. https:\/\/doi.org\/10.1089\/adt.2024.122.","journal-title":"Assay Drug Dev Technol"},{"key":"3225_CR75","unstructured":"Vogt M. Syringe barrel with varying silicone layer thicknesses, syringe comprising same and uses thereof. U.S. Patent 20240216613A1. 2008."},{"issue":"16","key":"3225_CR76","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1080\/10408398.2021.1875981","volume":"62","author":"OK Ozturk","year":"2022","unstructured":"Ozturk OK, Turasan H. Latest developments in the applications of microfluidization to modify the structure of macromolecules leading to improved physicochemical and functional properties. Crit Rev Food Sci Nutr. 2022;62(16):4481\u2013503.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"3225_CR77","first-page":"207","volume-title":"Fabrication of nanoemulsions by microfluidization","author":"F Villalobos-Castillejos","year":"2018","unstructured":"Villalobos-Castillejos F, Granillo-Guerrero VG, Leyva-Daniel DE, Alamilla-Beltr\u00e1n L, Guti\u00e9rrez-L\u00f3pez GF, Monroy-Villagrana A, et al. Fabrication of nanoemulsions by microfluidization. Nanoemulsions: Elsevier; 2018. p. 207\u201332."},{"issue":"2","key":"3225_CR78","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.pep.2005.08.015","volume":"45","author":"MP Dux","year":"2006","unstructured":"Dux MP, Barent R, Sinha J, Gouthro M, Swanson T, Barthuli A, et al. Purification and scale-up of a recombinant heavy chain fragment C of botulinum neurotoxin serotype E in Pichia pastoris GS115. Protein Expr Purif. 2006;45(2):359\u201367.","journal-title":"Protein Expr Purif"},{"issue":"4","key":"3225_CR79","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1039\/D0BM01755H","volume":"9","author":"K Desale","year":"2021","unstructured":"Desale K, Kuche K, Jain S. Cell-penetrating peptides (CPPs): an overview of applications for improving the potential of nanotherapeutics. Biomater Sci. 2021;9(4):1153\u201388.","journal-title":"Biomater Sci"},{"issue":"8","key":"3225_CR80","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1038\/s41433-021-01925-z","volume":"36","author":"SV Hunt","year":"2022","unstructured":"Hunt SV, Malhotra R. Bacteriostatic preserved saline for pain-free periocular injections. Eye. 2022;36(8):1546\u201352.","journal-title":"Eye"},{"issue":"5","key":"3225_CR81","first-page":"223","volume":"2","author":"M Turner","year":"2015","unstructured":"Turner M, Singhrao SK, Dennison SR, Morton LHG, Crean S. Challenging the Clostridium botulinum toxin type A (BoNT\/A) with a selection of microorganisms by culture methods and extended storage of used vials to assess the loss of sterility. J Dent Appl. 2015;2(5):223\u20138.","journal-title":"J Dent Appl"},{"issue":"7","key":"3225_CR82","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1038\/sj.eye.6702465","volume":"21","author":"J Menon","year":"2007","unstructured":"Menon J, Murray A. Microbial growth in vials of Botulinum toxin following use in clinic. Eye. 2007;21(7):995\u20137.","journal-title":"Eye"},{"issue":"2","key":"3225_CR83","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/asj\/sju072","volume":"35","author":"T Osaki","year":"2015","unstructured":"Osaki T, Osaki MH, Osaki TH, Sant\u2019Anna AE, Yu MCZ, Hofling-Lima AL. Absence of bacterial or fungal growth in vials of reconstituted botulinum toxin type A after storage. Aesthet Surg J. 2015;35(2):189\u201393.","journal-title":"Aesthet Surg J"},{"key":"3225_CR84","doi-asserted-by":"publisher","DOI":"10.2307\/jj.8763141","volume-title":"Death to beauty: the transformative history of Botox","author":"EM Helveston","year":"2024","unstructured":"Helveston EM. Death to beauty: the transformative history of Botox. Bloomington: Indiana University Press; 2024."},{"issue":"10","key":"3225_CR85","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.2174\/1567201818666210510165938","volume":"18","author":"S Singh","year":"2021","unstructured":"Singh S, Singha P. Effect of modifications in poly (lactide-co-glycolide)(PLGA) on drug release and degradation characteristics: a mini review. Curr Drug Deliv. 2021;18(10):1378\u201390.","journal-title":"Curr Drug Deliv"},{"issue":"18","key":"3225_CR86","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.3390\/polym16182606","volume":"16","author":"J Yang","year":"2024","unstructured":"Yang J, Zeng H, Luo Y, Chen Y, Wang M, Wu C, et al. Recent applications of PLGA in drug delivery systems. Polym. 2024;16(18):2606.","journal-title":"Polym"},{"issue":"25","key":"3225_CR87","doi-asserted-by":"publisher","first-page":"9196","DOI":"10.1021\/acs.iecr.1c00063","volume":"60","author":"W Si","year":"2021","unstructured":"Si W, Yang Q, Zong Y, Ren G, Zhao L, Hong M, et al. Toward understanding the effect of solvent evaporation on the morphology of PLGA microspheres by double emulsion method. Ind Eng Chem Res. 2021;60(25):9196\u2013205.","journal-title":"Ind Eng Chem Res"},{"issue":"1","key":"3225_CR88","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.msec.2010.09.013","volume":"31","author":"Y Mao","year":"2011","unstructured":"Mao Y, Dong Y, Lin P, Chu C, Sheng X, Guo C. Preparation of poly (l-lactic acid) microspheres by droplet-freezing process. Mater Sci Eng, C. 2011;31(1):9\u201313.","journal-title":"Mater Sci Eng, C"},{"issue":"8","key":"3225_CR89","doi-asserted-by":"publisher","first-page":"657","DOI":"10.3109\/02652041003739840","volume":"27","author":"IM El-Sherbiny","year":"2010","unstructured":"El-Sherbiny IM, Smyth HDC. Novel cryomilled physically cross-linked biodegradable hydrogel microparticles as carriers for inhalation therapy. J Microencapsul. 2010;27(8):657\u201368.","journal-title":"J Microencapsul"},{"issue":"2","key":"3225_CR90","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ijpharm.2008.04.042","volume":"364","author":"C Wischke","year":"2008","unstructured":"Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs in PLA\/PLGA microparticles. Int J Pharm. 2008;364(2):298\u2013327.","journal-title":"Int J Pharm"},{"issue":"2","key":"3225_CR91","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3390\/pharmaceutics14020359","volume":"14","author":"A Vlachopoulos","year":"2022","unstructured":"Vlachopoulos A, Karlioti G, Balla E, Daniilidis V, Kalamas T, Stefanidou M, et al. Poly (lactic acid)-based microparticles for drug delivery applications: an overview of recent advances. Pharmaceutics. 2022;14(2):359.","journal-title":"Pharmaceutics"},{"issue":"15","key":"3225_CR92","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.3390\/polym14153126","volume":"14","author":"S Pardeshi","year":"2022","unstructured":"Pardeshi S, Damiri F, Zehravi M, Joshi R, Kapare H, Prajapati MK, et al. Functional thermoresponsive hydrogel molecule to material design for biomedical applications. Polymers. 2022;14(15):3126.","journal-title":"Polymers"},{"key":"3225_CR93","doi-asserted-by":"publisher","first-page":"102239","DOI":"10.1016\/j.jddst.2020.102239","volume":"61","author":"LE de Souza","year":"2021","unstructured":"de Souza LE, Eckenstaler R, Syrowatka F, Beck-Broichsitter M, Benndorf RA, M\u00e4der K. Has PEG-PLGA advantages for the delivery of hydrophobic drugs? Risperidone as an example. J Drug Deliv Sci Technol. 2021;61:102239.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"08","key":"3225_CR94","doi-asserted-by":"publisher","first-page":"2130007","DOI":"10.1142\/S1793292021300073","volume":"16","author":"TZ Mehrizi","year":"2021","unstructured":"Mehrizi TZ. Hemocompatibility and hemolytic effects of functionalized nanoparticles on red blood cells: a recent review study. NANO. 2021;16(08):2130007.","journal-title":"NANO"},{"issue":"6","key":"3225_CR95","doi-asserted-by":"publisher","first-page":"524","DOI":"10.2174\/1566524021666210928152015","volume":"22","author":"TZ Mehrizi","year":"2022","unstructured":"Mehrizi TZ. An overview of the latest applications of platelet-derived microparticles and nanoparticles in medical technology 2010\u20132020. Curr Mol Med. 2022;22(6):524\u201339.","journal-title":"Curr Mol Med"},{"issue":"4","key":"3225_CR96","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jpha.2018.07.002","volume":"8","author":"C Su","year":"2018","unstructured":"Su C, Liu Y, He Y, Gu J. Analytical methods for investigating in vivo fate of nanoliposomes: a review. J Pharm Anal. 2018;8(4):219\u201325.","journal-title":"J Pharm Anal"},{"key":"3225_CR97","first-page":"1087","volume":"23","author":"RD Prasad","year":"2024","unstructured":"Prasad RD, Prasad RS, Prasad RB, Prasad SR, Singha SB, Singha D, et al. A review on modern characterization techniques for analysis of nanomaterials and biomaterials. ES Energy Environ. 2024;23:1087.","journal-title":"ES Energy Environ"},{"issue":"1","key":"3225_CR98","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1002\/med.21981","volume":"44","author":"P Gupta","year":"2024","unstructured":"Gupta P, Rai N, Verma A, Gautam V. Microscopy based methods for characterization, drug delivery, and understanding the dynamics of nanoparticles. Med Res Rev. 2024;44(1):138\u201368.","journal-title":"Med Res Rev"},{"issue":"3","key":"3225_CR99","doi-asserted-by":"publisher","first-page":"247","DOI":"10.2174\/1389201024666230522091958","volume":"25","author":"TZ Mehrizi","year":"2024","unstructured":"Mehrizi TZ, Mirzaei M, Ardestani MS. Pegylation, a successful strategy to address the storage and instability problems of blood products: review 2011\u20132021. Curr Pharm Biotechnol. 2024;25(3):247\u201367.","journal-title":"Curr Pharm Biotechnol"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-025-03225-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-025-03225-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T19:02:56Z","timestamp":1770318176000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-025-03225-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["3225"],"URL":"https:\/\/doi.org\/10.1208\/s12249-025-03225-1","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"18 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors of the manuscript have no conflict of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"38"}}